Apellis Pharmaceuticals, Inc. (APLS) Reports Q2 Loss, Tops Revenue Estimates
APLSApellis(APLS) ZACKS·2024-08-01 21:15

Apellis Pharmaceuticals, Inc. (APLS) came out with a quarterly loss of 0.28pershareversustheZacksConsensusEstimateofalossof0.28 per share versus the Zacks Consensus Estimate of a loss of 0.33. This compares to loss of 1.02pershareayearago.Thesefiguresareadjustedfornon−recurringitems.Thisquarterlyreportrepresentsanearningssurpriseof15.151.02 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 15.15%. A quarter ago, it was expected that this company would post a loss of 0.54 per share when it actually produced a loss of $0.54, delivering no surprise.Over the last four quarters, the company has sur ...